Form 4: Cryoport CEO Jerrell Shelton Reports Stock Transactions
SEC Form 4 Filing
Cryoport's CEO, Jerrell Shelton, reports acquisition and disposal of company stock and stock options.
Summary
- On March 14, 2025, Jerrell Shelton, CEO of Cryoport, acquired 30,000 shares of common stock at $0 and was granted options to purchase 75,000 shares.
- On March 17, 2025, Shelton sold 4,620 shares of common stock at a price of $6.2917 per share.
- Following these transactions, Shelton directly owns 765,399 shares of Cryoport common stock and options to purchase 75,000 shares.
- The restricted stock rights vest in four equal annual installments beginning March 14, 2026.
- The stock options vest monthly over four years, starting April 14, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The CEO acquired shares and options, which is positive, but also sold shares, which is less positive. The sale was for tax purposes, mitigating the negative impact.
Positives
- The CEO's acquisition of 30,000 shares could be interpreted as a positive signal about the company's future prospects.
- The granting of 75,000 stock options incentivizes the CEO to improve company performance.
Negatives
- The sale of 4,620 shares, while for tax purposes, could be viewed negatively by some investors.
Risks
- Executive stock sales can sometimes be perceived as a lack of confidence in the company, although this sale was explicitly for tax obligations related to vesting restricted stock rights.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge executive sentiment and potential future stock performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders' perception of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Acquisition of 30,000 shares and grant of options to purchase 75,000 shares. |
| 03/14/2026 | First vesting date for restricted stock rights. |
| 03/17/2025 | Sale of 4,620 shares of common stock. |
| 04/14/2025 | First monthly vesting date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.